A 2-Year Observational Study to Describe the Characteristics and Progression of Patients Suffering from Idiopathic Pulmonary Fibrosis Treated with Esbriet® in the Conditions of Use First published 27/05/2016 Last updated 14/03/2024 EU PAS number:EUPAS12456 Study Finalised